Ana Jaklenec, Ph.D.

AIMBE College of Fellows Class of 2022
For her work in controlled delivery of vaccines and heat-stable micronutrients for global health that has the ability to change the world.

Metal-Organic Nanoparticles Enable Better Vaccine Delivery, Stronger Immune Response

Via Genetic Engineering & Biotechnology News | March 6, 2024

Scientists from the Massachusetts Institute of Technology (MIT) and elsewhere have published a paper in Science Advances that describes a type of nanoparticle for delivering vaccines called a metal organic framework (MOF) that can potentially provoke a strong immune response at lower doses. The paper is titled “Zeolitic Imidazolate Frameworks Activate Endosomal Toll-like Receptors and Potentiate Immunogenicity of SARS-CoV-2 Spike Protein Trimer.”

In the study, which was done in mice, the researchers showed that the MOF successfully encapsulated and delivered part of the SARS-CoV-2 spike protein while simultaneously acting as an adjuvant once it broke down inside cells. More work is needed to ensure that the particles can be used safely in human vaccines, but these early results are promising… Continue reading.


Ana Jaklenec elected to the National Academy of Inventors

Via MIT | December 12, 2023

The National Academy of Inventors (NAI) announced the election of more than 160 people to their 2023 class of fellows, including two members of the MIT Koch Institute for Integrative Cancer Research, Daniel Anderson and Ana Jaklenec.

The highest professional distinction accorded solely to academic inventors, election to the NAI recognizes individuals who have created or facilitated outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society… Continue reading.


MIT’s Tiny Technologies Go to Washington

Via MIT | December 4, 2023

Cancer nanomedicine showcased at the White House Demo Day

On November 7, a team from the Marble Center for Cancer Nanomedicine showed a Washington D.C. audience several examples of how nanotechnologies developed at MIT can transform the detection and treatment of cancer and other diseases.

The team was one of 40 innovative groups featured at “American Possibilities: A White House Demo Day.” Technology on view spanning energy, artificial intelligence, climate, and health, highlighting advancements that contribute to building a better future for all Americans… Continue reading.


Microneedle Patch Printer Enables On-Demand Vaccine Manufacturing

Via Genetic Engineering & Biotechnology News | April 24, 2023

The portable instrument could increase global access to vaccines by simplifying their storage, distribution, and administration.

Researchers from the lab of Robert Langer, ScD, at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), say they have developed a printer for microneedle patches smaller than postage stamps that penetrate the skin to deliver vaccines, including the COVID-19 mRNA vaccine.

The research article, “A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines,” was published in Nature Biotechnology… Continue reading.


Microparticles could be used to deliver “self-boosting” vaccines

Via MIT | July 13, 2022

Most vaccines, from measles to Covid-19, require a series of multiple shots before the recipient is considered fully vaccinated. To make that easier to achieve, MIT researchers have developed microparticles that can be tuned to deliver their payload at different time points, which could be used to create “self-boosting” vaccines.

In a new study, the researchers describe how these particles degrade over time, and how they can be tuned to release their contents at different time points. The study also offers insights into how the contents can be protected from losing their stability as they wait to be released… Continue reading.


Dr. Ana Jaklenec Elected to the 2022 Class of the AIMBE College of Fellows

Via AIMBE | February 18, 2022

WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has announced the election of Ana Jaklenec, Ph.D., Research Scientist and co-Principal Investigator, Koch Institute For Integrative Cancer Research, Massachusetts Institute of Technology to its College of Fellows. Dr. Jaklenec was nominated, reviewed, and elected by peers and members of the AIMBE College of Fellows for her work in controlled delivery of vaccines and heat-stable micronutrients for global health that has the ability to change the world.

The College of Fellows is comprised of the top two percent of medical and biological engineers in the country. The most accomplished and distinguished engineering and medical school chairs, research directors, professors, innovators, and successful entrepreneurs comprise the College of Fellows. AIMBE Fellows are regularly recognized for their contributions in teaching, research, and innovation. AIMBE Fellows have been awarded the Nobel Prize, the Presidential Medal of Science and the Presidential Medal of Technology and Innovation, and many also are members of the National Academy of Engineering, National Academy of Medicine, and the National Academy of Sciences… Continue reading.